Delivery Order SPE2DE24DA017-SPE2D625F8NU5
- Not listed
- Arthrex Inc., a leading global provider of minimally invasive orthopedic medical technologies based in Naples, Florida, has been awarded a delivery order valued at $1,817.64 for an ACP MAX PRP System with ACDA under a Defense Logistics Agency Medical Supply Chain contract. The award, announced on August 29, 2025, is a fixed-price delivery order with economic price adjustment provisions and is set to be completed by September 4, 2025. This delivery order falls under Arthrex's larger Indefinite...
- Arthrex Inc. has been awarded a delivery order valued at $3,635.28 by the Defense Logistics Agency's Medical Supply Chain for an ACP MAX PRP System with ACDA functionality. The contract, issued on August 29, 2025, carries a fixed-price structure with economic price adjustment provisions and is scheduled for completion by September 4, 2025. This delivery order represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, a $471...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $7,270.56 on September 12, 2025, for the ACP MAX PRP System with ACDA. This fixed-price delivery order with economic price adjustment falls under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for supplying medical products to Department of Defense and Department of Veterans Affairs...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,029.40 on August 27, 2025, for the ACP MAX PRP System with ACDA (autologous conditioned plasma). This fixed-price delivery order with economic price adjustment is scheduled for completion by September 2, 2025, and represents performance under Arthrex's larger indefinite delivery contract with the Defense Logistics Agency's Medical Supply Chain. The order...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $1,817.64 delivery order from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, for an ACP MAX PRP (Autologous Conditioned Plasma Maximum Platelet-Rich Plasma) System with Autologous Conditioned Plasma technology. This fixed-price contract with economic price adjustment provisions is set to conclude by August 18, 2025, and represents a task order under Arthrex's larger Indefinite...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $20,710.80 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain for the ACP MAX PRP System (OUS/EU). Awarded on September 5, 2025, with an ultimate completion date of September 10, 2025, this delivery order is issued under a larger indefinite delivery contract (IDC SPE2DE24D0020) valued at $471 million and running through September 1, 2029. The contract includes economic...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $8,250 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 7, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $52,879.14 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for an ACP MAX PRP System with ACDA technology. This delivery order represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) valued at $471 million and running through September 1, 2029. The contract carries no set-aside designation, reflecting Arthrex's...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a fixed-price delivery order valued at $1,540.80 from the Defense Logistics Agency's Medical Supply Chain on June 24, 2025, for ACP Kit Series I products. The contract, which operates under a non-competitive procurement with no set-aside designation, is scheduled for completion by June 27, 2025, with performance occurring in Naples, Florida. This delivery order represents a continuation...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F8NU5Delivery Order
Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies, was awarded a fixed-price delivery order valued at $3,029.40 by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025, for the ACP MAX PRP System with ACDA. The delivery order, which is not set-aside for any specific business category, has an ultimate completion date of July 29, 2025, and will be performed in Naples, Florida. This award represents a task order under Arthrex's broader Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and running through September 2029, which provides VA medical centers nationwide with access to Arthrex's comprehensive portfolio of orthopedic surgical products and implants. As a Subchapter S Corporation headquartered in Naples, Florida, Arthrex has established itself as a primary supplier to federal healthcare systems, particularly the Department of Veterans Affairs and Department of Defense. The company specializes in developing and manufacturing advanced orthopedic solutions including surgical implants, arthroscopic instruments, suture anchors, and specialized surgical kits. This delivery order for the ACP MAX PRP System continues Arthrex's track record of supporting government healthcare initiatives with innovative orthopedic technologies designed to enhance surgical capabilities and patient outcomes for veterans and military personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 7/24/25 |